**Lipid nanoparticles improve ex vivo gene editing of human hematopoietic cells.**
2022.
Whole transcriptomic analysis 24 hours after treatment of CD4+ T cells from 3 healthy donors and of HSPC (form 3 replicates) for CD40LG editing treated with LNPs. As controls, cells untreated (UT), mock electroporated or treated with LNPs formulated without RNA (Empty LNPs) were employed.
---
### Analyses ###
Stanrdard RNA-seq pipeline on 36 samples: 18 samples of T cells and 18 samples of HSPCs.<br>
In details, for both cell types (i.e., T and HSPC) DGE analysis on samples was performed with DESeq2, comparing dfferent groups (adding donor covariate for T cells):
Enrichment on (positive or negative) differentially expressed genes (FDR < 0.05) and GSEA on pre-ranked gene lists (ordered by log2 Fold Change values) agasint the MSigDB Hallmark database were performed with ClusterProfiler: